ATORVASTATIN CALCIUM
- Product NDC
- 72189-291
- 11-digit product format
- 721890291
- Labeler code
- 72189
- Product ID
- 72189-291_2c2947eb-f8b1-c0f8-e063-6394a90aa6f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA213853
- Marketing category
- ANDA
- Marketing start
- 2021-11-10
- Substance
- ATORVASTATIN
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ATORVASTATIN CALCIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATORVASTATIN | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A0JWA85V8F |
| Rxcui | 617310 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-291-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-291 | ATORVASTATIN CALCIUM TABLET [DIRECTRX] | 2 | Current NDC, Legacy NDC, 1 package rows | 20250121_d076309f-313a-1c71-e053-2995a90a7bb7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-291-90 | 72189029190 | 90 TABLET in 1 BOTTLE (72189-291-90) | 90 tablet | 2021-11-10 | 0000-00-00 | No | No | Current |